Search

Author/Creator Lafon, Ingrid

1. Early achievement of measurable residual disease negativity in the treatment of multiple myeloma as predictor of outcome. (11th March 2022)

Authors:
Baumelou, Marion; Payssot, Alexandre; Row, Celine; Racine, Jessica; Lafon, Ingrid; Bastie, Jean‐Noél; Chevreux, Steeve; Chrétien, Marie‐Lorraine; Maynadié, Marc; Caillot, Denis; Guy, Julien
Journal:
British journal of haematology
Issue:
Volume 197:Number 6(2022)
Page Start:
e82
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Evolution of procalcitonin, C‐reactive protein and fibrinogen levels in neutropenic leukaemia patients with invasive pulmonary aspergillosis or mucormycosis. Issue 6 (2nd March 2016)

Authors:
Roques, Marjorie; Chretien, Marie Lorraine; Favennec, Camille; Lafon, Ingrid; Ferrant, Emmanuelle; legouge, Caroline; Plocque, Alexia; Golfier, Camille; Duvillard, Laurence; Amoureux, Lucie; Bastie, Jean Noel; Maurin‐Bernier, Lory; Dalle, Frederic; Caillot, Denis
Journal:
Mycoses
Issue:
Volume 59:Issue 6(2016)
Page Start:
383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Is It Time to Include CT "Reverse Halo Sign" and qPCR Targeting Mucorales in Serum to EORTC-MSG Criteria for the Diagnosis of Pulmonary Mucormycosis in Leukemia Patients?. (8th November 2016)

Authors:
Caillot, Denis; Valot, Stéphane; Lafon, Ingrid; Basmaciyan, Louise; Chretien, Marie Lorraine; Sautour, Marc; Millon, Laurence; Legouge, Caroline; Payssot, Alexandre; Dalle, Frédéric
Journal:
Open forum infectious diseases
Issue:
Volume 3:Number 4(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗